Literature DB >> 17329803

A high-resolution structure of ligand-free human glutamate carboxypeptidase II.

Cyril Barinka1, Jana Starkova, Jan Konvalinka, Jacek Lubkowski.   

Abstract

Human glutamate carboxypeptidase II (GCPII; EC 3.4.17.21) is an established marker for prostate-cancer diagnosis as well as a candidate therapeutic target for the treatment of diverse pathologies that involve glutamatergic transmission. Structural data on GCPII are thus valuable for the design and optimization of GCPII-specific inhibitors and diagnostic probes. The currently available structure of ligand-free GCPII was refined to a resolution of 3.5 A. This work reports the structure of the protein refined to 1.65 A resolution, with crystallographic values of R = 0.207 and R(free) = 0.228. The new structure extends the resolution appreciably and the new model based on this data shows significant differences when compared with the previously published model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329803      PMCID: PMC2330195          DOI: 10.1107/S174430910700379X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  16 in total

1.  Efficient anisotropic refinement of macromolecular structures using FFT.

Authors:  G N Murshudov; A A Vagin; A Lebedev; K S Wilson; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-01-01

Review 2.  NAAG peptidase inhibitors and their potential for diagnosis and therapy.

Authors:  Jia Zhou; Joseph H Neale; Martin G Pomper; Alan P Kozikowski
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

3.  Pentaerythritol propoxylate: a new crystallization agent and cryoprotectant induces crystal growth of 2-methylcitrate dehydratase.

Authors:  Andrew M Gulick; Alexander R Horswill; James B Thoden; Jorge C Escalante-Semerena; Ivan Rayment
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-01-24

4.  Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II.

Authors:  Cyril Barinka; Markéta Rinnová; Pavel Sácha; Camilo Rojas; Pavel Majer; Barbara S Slusher; Jan Konvalinka
Journal:  J Neurochem       Date:  2002-02       Impact factor: 5.372

5.  Structure of membrane glutamate carboxypeptidase.

Authors:  N D Rawlings; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1997-05-23

6.  Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase.

Authors:  Mindy I Davis; Melanie J Bennett; Leonard M Thomas; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-18       Impact factor: 11.205

Review 7.  The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.

Authors:  Joseph H Neale; Rafal T Olszewski; Laura M Gehl; Barbara Wroblewska; Tomasz Bzdega
Journal:  Trends Pharmacol Sci       Date:  2005-09       Impact factor: 14.819

8.  Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II.

Authors:  C H Halsted; E H Ling; R Luthi-Carter; J A Villanueva; J M Gardner; J T Coyle
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

9.  Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.

Authors:  D G Bostwick; A Pacelli; M Blute; P Roche; G P Murphy
Journal:  Cancer       Date:  1998-06-01       Impact factor: 6.860

10.  Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.

Authors:  J T Pinto; B P Suffoletto; T M Berzin; C H Qiao; S Lin; W P Tong; F May; B Mukherjee; W D Heston
Journal:  Clin Cancer Res       Date:  1996-09       Impact factor: 12.531

View more
  17 in total

Review 1.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.

Authors:  Ying Chen; Catherine A Foss; Youngjoo Byun; Sridhar Nimmagadda; Mrudula Pullambhatla; James J Fox; Mark Castanares; Shawn E Lupold; John W Babich; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 3.  PET imaging in prostate cancer: focus on prostate-specific membrane antigen.

Authors:  Ronnie C Mease; Catherine A Foss; Martin G Pomper
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

4.  Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II.

Authors:  Michal Navrátil; Jakub Ptáček; Pavel Šácha; Jana Starková; Jacek Lubkowski; Cyril Bařinka; Jan Konvalinka
Journal:  FEBS J       Date:  2014-06-17       Impact factor: 5.542

Review 5.  Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.

Authors:  James J Vornov; Diane Peters; Mike Nedelcovych; Kristen Hollinger; Rana Rais; Barbara S Slusher
Journal:  Neurochem Res       Date:  2019-11-20       Impact factor: 3.996

6.  Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.

Authors:  Anna Plechanovová; Youngjoo Byun; Glenda Alquicer; L'ubica Skultétyová; Petra Mlčochová; Adriana Němcová; Hyung-Joon Kim; Michal Navrátil; Ronnie Mease; Jacek Lubkowski; Martin Pomper; Jan Konvalinka; Lubomír Rulíšek; Cyril Bařinka
Journal:  J Med Chem       Date:  2011-10-11       Impact factor: 7.446

7.  Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.

Authors:  Cyril Barinka; Youngjoo Byun; Crystal L Dusich; Sangeeta R Banerjee; Ying Chen; Mark Castanares; Alan P Kozikowski; Ronnie C Mease; Martin G Pomper; Jacek Lubkowski
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

8.  Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.

Authors:  Cyril Barinka; Klara Hlouchova; Miroslava Rovenska; Pavel Majer; Miroslawa Dauter; Niyada Hin; Yao-Sen Ko; Takashi Tsukamoto; Barbara S Slusher; Jan Konvalinka; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2008-01-05       Impact factor: 5.469

9.  Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.

Authors:  Haofan Wang; Youngjoo Byun; Cyril Barinka; Mrudula Pullambhatla; Hyo-Eun C Bhang; James J Fox; Jacek Lubkowski; Ronnie C Mease; Martin G Pomper
Journal:  Bioorg Med Chem Lett       Date:  2009-10-24       Impact factor: 2.823

10.  N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.

Authors:  Ronnie C Mease; Crystal L Dusich; Catherine A Foss; Hayden T Ravert; Robert F Dannals; Jurgen Seidel; Andrew Prideaux; James J Fox; George Sgouros; Alan P Kozikowski; Martin G Pomper
Journal:  Clin Cancer Res       Date:  2008-05-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.